What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials

Health
By Walt Bogdanich and Carson Kessler from NYT Health https://ift.tt/mBRvPj4
via IFTTT Alzheimer's Disease, Drugs (Pharmaceuticals), Brain, Leqembi (Drug), Genetics and Heredity, Clinical Trials, Hemorrhagic Stroke, Retirement Communities and Assisted Living, Elderly, Medicine and Health Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda